# The Effects of Intermittent Hypoxic-hyperoxic Preconditioning for Patients Undergoing Cardiopulmonary Bypass.

Study · id `cardio:ct-nct04833283` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04833283](<https://clinicaltrials.gov/study/NCT04833283>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04833283

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.

## Technical summary

Registry record NCT04833283. Randomized; single masking; primary purpose supportive care. Start 2021-01-25 (actual); primary completion 2022-05-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 115 participants (enrolled count; ClinicalTrials.gov record NCT04833283, source copy `cardio:ctgov-nct04833283-2022-12-07`, retrieved 2026-10-26)
- Started: 2021-01-25 (actual) (ClinicalTrials.gov record NCT04833283, source copy `cardio:ctgov-nct04833283-2022-12-07`, retrieved 2026-10-26)
- Primary completion: 2022-05-15 (actual) (ClinicalTrials.gov record NCT04833283, source copy `cardio:ctgov-nct04833283-2022-12-07`, retrieved 2026-10-26)
- Completion: 2022-12-01 (actual) (ClinicalTrials.gov record NCT04833283, source copy `cardio:ctgov-nct04833283-2022-12-07`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT04833283, source copy `cardio:ctgov-nct04833283-2022-12-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04833283-2022-12-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effects of Intermittent Hypoxic-hyperoxic Preconditioning for Patients Undergoing Cardiopulmonary Bypass.
- Condition: Valvular Heart Disease
- Condition: Aortic Arch Aneurysm
- Condition: Surgery
- Intervention (Device): ReOxy Cardio device, intermittent hypoxic-hyperoxic training ( IHHT)
- Intervention (Device): ReOxy Cardio device
- Lead sponsor: I.M. Sechenov First Moscow State Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: I.M. Sechenov First Moscow State Medical University (`cardio:org-i-m-sechenov-first-moscow-state-medical-university`)

## Provenance

Content hash: 2150ccfaae58f120beac07d2b85a3081792fc81ea964145ed5ce995104a1eb5a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
